Paculanang, Danny Lious L.

HRN: 28-56-39  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
CEFTRIAXONE 1G (VIAL)
02/14/2026
02/20/2026
IVT
2g
OD
T/C Leukemia; Leukocytosis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: